Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban for Left Ventricular Thrombus Post-MI
NCT05208398Phase 3Completed
- Sponsor
- Saud Al-Babtain Cardiac Center
- Start
- Feb 2018
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of apixaban in left ventricular thrombus (LVT), sponsored by Saud Al-Babtain Cardiac Center. Started Feb 2018; status: completed.
02
Drugs
apixaban
03
Conditions
left ventricular thrombus (LVT)
Beyond the preview
Go deeper on NCT05208398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05208398.